Driving change in Cell & Gene Therapies: Key learnings from the SITC Virtual Summit

Chris Learn, Head of Cell and Gene COE at Parexel discusses his participation at the recent Clinical Research Virtual Summit hosted by the Society for Immunotherapy of Cancer, and the implications for clinical research.

Return to Insights Center

Related Insights

Podcast

Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training

Jun 28, 2024

Blog

Making cell and gene therapy more accessible in the treatment of solid tumors

Jun 4, 2024

Podcast

De-risking Drug Development | Episode 1: How to drive value in pre-clinical development

May 28, 2024

Blog

SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change

Aug 24, 2022

Webinar

Advancing mRNA-based drug development and vaccine manufacturing

Jul 1, 2024

Blog

Chris Learn joins Parexel as Head of the Cell and Gene Center of Excellence

Apr 4, 2022

Article

Five strategies for meeting the requirements of Project Optimus and improving the chances of approval

Nov 10, 2022

Article

Q&A Project Optimus: What you need to know

Oct 11, 2022

Blog

What Do the Next 10 Years Hold for CRISPR?

Jul 27, 2022

Video

Cell & Gene Therapies: A Regulatory Update

Jul 22, 2022

Blog

Parexel names first Patient Ambassador

Jun 17, 2022

Blog

Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial

Nov 19, 2021